Adherium Limited (ADR.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -6.1 Million AUD | 32.42% |
| 2023 | -9.03 Million AUD | -73.78% |
| 2022 | -5.19 Million AUD | 65.75% |
| 2021 | -15.17 Million AUD | -231.11% |
| 2020 | -4.58 Million AUD | -500.79% |
| 2019 | -763 Thousand AUD | 93.7% |
| 2018 | -12.11 Million AUD | 46.8% |
| 2017 | -22.77 Million AUD | 16.29% |
| 2016 | -27.21 Million AUD | 19.92% |
| 2015 | -33.98 Million AUD | -1701.67% |
| 2014 | -1.88 Million AUD | 45.89% |
| 2013 | -3.48 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -6.1 Million AUD | 32.42% |
| 2024 Q2 | -3.12 Million AUD | 0.0% |
| 2024 Q4 | -6.1 Million AUD | 0.0% |
| 2023 Q4 | -9.03 Million AUD | 0.0% |
| 2023 Q2 | -12.76 Million AUD | 0.0% |
| 2023 FY | -9.03 Million AUD | -73.78% |
| 2022 Q2 | -10.65 Million AUD | 0.0% |
| 2022 Q4 | -5.19 Million AUD | 0.0% |
| 2022 FY | -5.19 Million AUD | 65.75% |
| 2021 Q2 | -174 Thousand AUD | 0.0% |
| 2021 Q4 | -15.17 Million AUD | 0.0% |
| 2021 FY | -15.17 Million AUD | -231.11% |
| 2020 Q4 | -4.58 Million AUD | 0.0% |
| 2020 FY | -4.58 Million AUD | -500.79% |
| 2020 Q2 | 3.49 Million AUD | 0.0% |
| 2019 Q2 | -4.09 Million AUD | 0.0% |
| 2019 Q4 | -763 Thousand AUD | 0.0% |
| 2019 FY | -763 Thousand AUD | 93.7% |
| 2018 FY | -12.11 Million AUD | 46.8% |
| 2018 Q4 | -12.11 Million AUD | 0.0% |
| 2018 Q2 | -14.93 Million AUD | 0.0% |
| 2017 Q4 | -22.77 Million AUD | 0.0% |
| 2017 FY | -22.77 Million AUD | 16.29% |
| 2017 Q2 | -29.52 Million AUD | 0.0% |
| 2016 FY | -27.21 Million AUD | 19.92% |
| 2015 FY | -33.98 Million AUD | -1701.67% |
| 2014 FY | -1.88 Million AUD | 45.89% |
| 2013 FY | -3.48 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 76.048% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -62.906% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -69.409% |
| Anteris Technologies Ltd | -28.49 Million AUD | 78.581% |
| Control Bionics Limited | -19.02 Thousand AUD | -31990.911% |
| CardieX Limited | 2.74 Million AUD | 322.273% |
| Compumedics Limited | 5.08 Million AUD | 219.999% |
| Cochlear Limited | -269.9 Million AUD | 97.738% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 973.805% |
| Cyclopharm Limited | -7.49 Million AUD | 18.599% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 61.122% |
| Nova Eye Medical Limited | -2.8 Million AUD | -117.856% |
| HeraMED Limited | -799.34 Thousand AUD | -663.664% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 142.149% |
| ImpediMed Limited | -23.48 Million AUD | 74.012% |
| InhaleRx Limited | -155.54 Thousand AUD | -3824.506% |
| LBT Innovations Limited | -604 Thousand AUD | -910.651% |
| Micro-X Limited | 826.99 Thousand AUD | 838.131% |
| Neurotech International Limited | -2.11 Million AUD | -189.239% |
| OncoSil Medical Limited | -4.43 Million AUD | -37.773% |
| PolyNovo Limited | -30.52 Million AUD | 80.003% |
| Respiri Limited | 413.68 Thousand AUD | 1575.585% |
| SomnoMed Limited | -15.16 Million AUD | 59.741% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -15.09% |
| Uscom Limited | -1.53 Million AUD | -298.811% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -49.508% |